Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Clinical Trial of Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis

NCT07243366 is registered in ClinicalTrials.gov with Guangdong ProCapZoom Biosciences Co., Ltd. as lead sponsor.

NCT NCT07243366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07243366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Clinical Trial of Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis
Lead sponsor
Guangdong ProCapZoom Biosciences Co., Ltd.
Phase
Phase 1
Overall status
Not yet recruiting
Start date
November 25, 2025
Completion date
November 30, 2027
Enrollment
15 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

refractory myasthenia gravis